Promoter sequence, expression, and fine chromosomal mapping of the human gene (MLP) encoding the MARCKS-like protein: identification of neighboring and linked polymorphic loci for MLP and MACS and use in the evaluation of human neural tube defects.

The MARCKS-like protein (MLP), also known as F52, MacMARCKS, or MARCKS-related protein, is a widely distributed substrate for protein kinase C (PKC). Recent studies using gene disruption in vivo have demonstrated the importance of both MARCKS and MLP to the development of the central nervous system; specifically, mice lacking either protein exhibit a high frequency of neural tube defects. We isolated a genomic clone for human MLP and discovered a directly linked polymorphism (MLP1) useful for genetic linkage analysis. The MLP promoter was 71% identical over 433 bp to that of the corresponding mouse gene, Mlp, with conservation of many putative transcription factor-binding sites; it was only 36% identical over 433 bp to the promoter of the human gene, MACS, which encodes the MLP homologue MARCKS. This 433-bp fragment drove expression of an MLP-beta-galactosidase transgene in a tissue-specific and developmental expression pattern that was similar to that observed for the endogenous gene, as shown by in situ hybridization histochemistry. In contrast to MACS, the MLP and Mlp promoters contain a TATA box approximately 40 bp 5' of the presumed transcription initiation site. MLP was localized to chromosome 1p34-->1pter by analysis of human-mouse somatic cell hybrid DNA and to 1p34 by fluorescence in situ hybridization. Radiation hybrid mapping of MLP placed it between genetic markers D1S511 (LOD > 3.0) and WI9232. MACS was localized to 6q21 between D6S266 (LOD > 3.0) and AFM268uh5 by the same technique. We tested the novel MLP1 polymorphism and the MACS flanking markers in a series of 43 Caucasian simplex families in which the affected child had a lumbosacral myelomeningocele. We found no evidence of linkage disequilibrium, suggesting that these loci were not major genes for spina bifida in these families. Nonetheless, the identification of linked and neighboring polymorphisms for MACS and MLP should permit similar genetic studies in other groups of patients with neural tube defects and other neurodevelopmental abnormalities.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  A. Nairn,et al.  Widespread Neuronal Ectopia Associated with Secondary Defects in Cerebrocortical Chondroitin Sulfate Proteoglycans and Basal Lamina in MARCKS-Deficient Mice , 1997, Experimental Neurology.

[3]  B S Weir,et al.  Power studies for the transmission/disequilibrium tests with multiple alleles. , 1997, American journal of human genetics.

[4]  W J Ewens,et al.  The TDT and other family-based tests for linkage disequilibrium and association. , 1996, American journal of human genetics.

[5]  P. Deloukas,et al.  A Gene Map of the Human Genome , 1996, Science.

[6]  A. Nairn,et al.  Developmental expression of MARCKS and protein kinase C in mice in relation to the exencephaly resulting from MARCKS deficiency. , 1996, Brain research. Developmental brain research.

[7]  G. Fishell,et al.  Disruption of the MacMARCKS gene prevents cranial neural tube closure and results in anencephaly. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Tonegawa,et al.  Neural tube defects and abnormal brain development in F52-deficient mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Stumpo,et al.  MARCKS deficiency in mice leads to abnormal brain development and perinatal death. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  N. Dracopoli,et al.  Current protocols in human genetics , 1994 .

[11]  A. Copp,et al.  Etiology and pathogenesis of human neural tube defects: insights from mouse models. , 1994, Current opinion in pediatrics.

[12]  J. Weissenbach,et al.  A method for constructing radiation hybrid maps of whole genomes , 1994, Nature Genetics.

[13]  D. Stumpo,et al.  Protein kinase C-mediated phosphorylation and calmodulin binding of recombinant myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein. , 1994, The Journal of biological chemistry.

[14]  P. Blackshear,et al.  Nucleotide sequence, expression, and chromosomal mapping of Mrp and mapping of five related sequences. , 1993, Genomics.

[15]  W. Ewens,et al.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.

[16]  P. Blackshear The MARCKS family of cellular protein kinase C substrates. , 1993, The Journal of biological chemistry.

[17]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[18]  A. Aderem The Marcks brothers: A family of protein kinase C substrates , 1992, Cell.

[19]  A. Aderem,et al.  MacMARCKS, a novel member of the MARCKS family of protein kinase C substrates , 1992, Cell.

[20]  D. Stumpo,et al.  Chromosomal mapping of the human (MACS) and mouse (Macs) genes encoding the MARCKS protein. , 1992, Genomics.

[21]  D. Stumpo,et al.  Characteristics of the F52 protein, a MARCKS homologue. , 1992, The Journal of biological chemistry.

[22]  W. Young,et al.  Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  D. Harlan,et al.  The human myristoylated alanine-rich C kinase substrate (MARCKS) gene (MACS). Analysis of its gene product, promoter, and chromosomal localization. , 1991, The Journal of biological chemistry.

[24]  T. Umekage,et al.  A mouse brain cDNA encodes a novel protein with the protein kinase C phosphorylation site domain common to MARCKS , 1991, FEBS letters.

[25]  K. Struhl,et al.  Yeast and human TATA-binding proteins have nearly identical DNA sequence requirements for transcription in vitro , 1990, Molecular and cellular biology.

[26]  D. Ghosh,et al.  A relational database of transcription factors. , 1990, Nucleic acids research.

[27]  H. Cann,et al.  Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. , 1990, Genomics.

[28]  R. Lemire,et al.  Neural Tube Defects , 1988, JAMA.

[29]  R. Eddy,et al.  Interleukin 2 (IL2) is assigned to human chromosome 4 , 1984, Somatic cell and molecular genetics.

[30]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[31]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M C Speer,et al.  A microsatellite genetic linkage map of human chromosome 18. , 1993, Genomics.

[33]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .

[34]  Shows Tb Human genome organization of enzyme loci and metabolic diseases. , 1983 .

[35]  T. Shows,et al.  Mapping the human genome, cloned genes, DNA polymorphisms, and inherited disease. , 1982, Advances in human genetics.

[36]  K. Hirschhorn,et al.  Advances in Human Genetics , 1982, Springer US.

[37]  G. S. Whitt,et al.  Isozymes : current topics in biological and medical research , 1977 .